Biocompatibility of mannan nanogel - Safe interaction with plasma proteins

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 7, 2012, Pages 1043-1051

  Ferreira, Sílvia A ^a   Oslakovic, Cecilia ^b   Cukalevski, Risto ^c   Frohm, Birgitta ^c   Dahlbäck, Björn ^b   Linse, Sara ^c   Gama, Francisco M ^a   Cedervall, Tommy ^c  

^a UNIVERSITY OF MINHO   (Portugal)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Biocompatibility; Biosafety; Coagulation; Fibrillation; Mannan nanogel; Protein corona

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; DODECYL SULFATE SODIUM; FIBRIN; MANNAN; MANNAN NANOGEL; NANOMATERIAL; NANOPARTICLE; PLASMA PROTEIN; POLYMER; SERUM ALBUMIN; THIOFLAVINE; THROMBIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIOSAFETY; BIOTECHNOLOGY; BLOOD CLOTTING; CENTRIFUGATION; CIRCULAR DICHROISM; CONTROLLED STUDY; FIBRINOLYSIS; FLUORESCENCE ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYDROGEL; MASS SPECTROMETRY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; THROMBIN TIME;

AMYLOID BETA-PEPTIDES; ANTIGEN-PRESENTING CELLS; APOLIPOPROTEIN A-I; BETA 2-MICROGLOBULIN; BLOOD COAGULATION; BLOOD PROTEINS; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; HUMANS; MANNANS; MATERIALS TESTING; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THIAZOLES; THROMBIN;

EID: 84860821259     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.04.015     Document Type: Article

References (66)

1. A.V. Kabanov, and S.V. Vinogradov Nanogels as pharmaceutical carriers: finite networks of infinite capabilities Angew. Chem. Int. Ed. 48 2009 5418 5429
2. J.K. Oh Engineering of nanometer-sized cross-linked hydrogels for biomedical applications Can. J. Chem. 88 2010 173 184
3. S.A. Ferreira, P. Pereira, P. Sampaio, P.J.G. Coutinho, and F.M. Gama Supramolecular assembled nanogel made of mannan J. Colloid Interface Sci. 361 2011 97 108
4. V. Apostolopoulos, G.A. Pietersz, B.E. Loveland, M.S. Sandrin, and I.F. McKenzie Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses Proc. Natl. Acad. Sci. U.S.A. 92 1995 10128 10132
5. X.G. Gu, M. Schmitt, A. Hiasa, Y. Nagata, H. Ikeda, Y. Sasaki, K. Akiyoshi, J. Sunamoto, H. Nakamura, K. Kuribayashi, and H. Shiku A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas Cancer Res. 58 1998 3385 3390
6. V. Sihorkar, and S.P. Vyas Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization J. Pharm. Pharm. Sci. 4 2001 138 158
7. A. Gupta, R.K. Gupta, and G.S. Gupta Targeting cells for drug and gene delivery: emerging applications of mannans and mannan binding lectins J. Sci. Ind. Res. 68 2009 465 483
8. A. Avrameas, D. McIlroy, A. Hosmalin, B. Autran, P. Debre, M. Monsigny, A.C. Roche, and P. Midoux Expression of a mannose/fucose membrane lectin on human dendritic cells Eur. J. Immunol. 26 1996 394 400
9. M. Fukasawa, Y. Shimizu, K. Shikata, M. Nakata, R. Sakakibara, N. Yamamoto, M. Hatanaka, and T. Mizuochi Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes FEBS Lett. 441 1998 353 356
10. V. Apostolopoulos, and I.F. McKenzie Role of the mannose receptor in the immune response Curr. Mol. Med. 1 2001 469 474
11. T. Cedervall, I. Lynch, M. Foy, T. Berggard, S.C. Donnelly, G. Cagney, S. Linse, and K.A. Dawson Detailed identification of plasma proteins adsorbed on copolymer nanoparticles Angew. Chem. Int. Ed Engl. 46 2007 5754 5756
12. T. Cedervall, I. Lynch, S. Lindman, T. Berggård, E. Thulin, H. Nilsson, K.A. Dawson, and S. Linse Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles Proc. Natl. Acad. Sci. U.S.A. 104 2007 2050 2055
13. E. Hellstrand, I. Lynch, A. Andersson, T. Drakenberg, B. Dahlbäck, K.A. Dawson, S. Linse, and T. Cedervall Complete high-density lipoproteins in nanoparticle corona FEBS J. 276 2009 3372 3381
14. P. Aggarwal, J.B. Hall, C.B. McLeland, M.A. Dobrovolskaia, and S.E. McNeil Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Deliv. Rev. 61 2009 428 437
15. M.P. Monopoli, D. Walczyk, A. Campbell, G. Elia, I. Lynch, F.B. Bombelli, and K.A. Dawson Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles J. Am. Chem. Soc. 133 2011 2525 2534
16. M. Lundqvist, I. Sethson, and B.-H. Jonsson Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability Langmuir 20 2004 10639 10647
17. X.R. Xia, N.A. Monteiro-Riviere, and J.E. Riviere An index for characterization of nanomaterials in biological systems Nat. Nanotechnol. 5 2010 671 675
18. W. Shang, J.H. Nuffer, V.A. Muñiz-Papandrea, W. Colón, R.W. Siegel, and J.S. Dordick Cytochrome c on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity Small 5 2009 470 476
19. P. Roach, D. Farrar, and C.C. Perry Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry J. Am. Chem. Soc. 128 2006 3939 3945
20. M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K.A. Dawson Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts Proc. Natl. Acad. Sci. U.S.A. 105 2008 14265 14270
21. D. Dell'Orco, M. Lundqvist, C. Oslakovic, T. Cedervall, and S. Linse Modeling the time evolution of the nanoparticle-protein corona in a body fluid PLoS One 5 2010 e10949
22. E. Casals, T. Pfaller, A. Duschl, G.J. Oostingh, and V. Puntes Time evolution of the nanoparticle protein corona ACS Nano 4 2010 3623 3632
23. D. Walczyk, F.B. Bombelli, M.P. Monopoli, I. Lynch, and K.A. Dawson What the cell sees in bionanoscience J. Am. Chem. Soc. 132 2010 5761 5768
24. G. Maiorano, S. Sabella, B. Sorce, V. Brunetti, M.A. Malvindi, R. Cingolani, and P.P. Pompa Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response ACS Nano 4 2010 7481 7491
25. M. Lundqvist, J. Stigler, T. Cedervall, T. Berggård, M.B. Flanagan, I. Lynch, G. Elia, and K. Dawson The evolution of the protein corona around nanoparticles: a test study ACS Nano 5 2011 7503 7509
26. S. Nagayama, K. Ogawara, Y. Fukuoka, K. Higaki, and T. Kimura Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics Int. J. Pharm. 342 2007 215 221
27. B.D. Chithrani, and W.C.W. Chan Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes Nano Lett. 7 2007 1542 1550
28. G. Oberdörster Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology J. Intern. Med. 267 2010 89 105
29. M.S. Ehrenberg, A.E. Friedman, J.N. Finkelstein, G. Oberdörster, and J.L. McGrath The influence of protein adsorption on nanoparticle association with cultured endothelial cells Biomaterials 30 2009 603 610
30. I. Lynch, T. Cedervall, M. Lundqvist, C. Cabaleiro-Lago, S. Linse, and K.A. Dawson The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century Adv. Colloid Interface Sci. 134-135 2007 167 174
31. X. Jiang, S. Weise, M. Hafner, C. Rocker, F. Zhang, W.J. Parak, and G.U. Nienhaus Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding J. R. Soc. Interface 7 Suppl. 1 2010 S5 S13
32. A. Lesniak, A. Campbell, M.P. Monopoli, I. Lynch, A. Salvati, and K.A. Dawson Serum heat inactivation affects protein corona composition and nanoparticle uptake Biomaterials 31 2010 9511 9518
33. M.A. Dobrovolskaia, P. Aggarwal, J.B. Hall, and S.E. McNeil Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharm. 5 2008 487 495
34. I. Lynch, and K.A. Dawson Protein-nanoparticle interactions Nano Today 3 2008 40 47
35. T.A. Faunce, J. White, and K.I. Matthaei Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines Nanomedicine (Lond.) 3 2008 859 866
36. I. Fenoglio, B. Fubini, E. Ghibaudi, and F. Turci Multiple aspects of the interaction of biomacromolecules with inorganic surfaces Adv. Drug Deliv. Rev. 63 2011 1186 1209
37. Z.J. Deng, M. Liang, M. Monteiro, I. Toth, and R.F. Minchin Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation Nat. Nanotechnol. 6 2010 39 44
38. J. Kim, J.W. Grate, and P. Wang Nanostructures for enzyme stabilization Chem. Eng. Sci. 61 2006 1017 1026
39. S. Koutsopoulos, K. Patzsch, W.T.E. Bosker, and W. Norde Adsorption of trypsin on hydrophilic and hydrophobic surfaces Langmuir 23 2007 2000 2006
40. J.E. Gagner, M.D. Lopez, J.S. Dordick, and R.W. Siegel Effect of gold nanoparticle morphology on adsorbed protein structure and function Biomaterials 32 2011 7241 7252
41. R. Cukalevski, M. Lundqvist, C. Oslakovic, B. Dahlbäck, S. Linse, and T. Cedervall Structural changes in apolipoproteins bound to nanoparticles Langmuir 27 2011 14360-14269
42. T. Cedervall, L.-A. Hansson, M. Lard, B. Frohm, and S. Linse Food chain transport of nanoparticles affects behaviour and fat metabolism in fish PLoS One 7 2012 e32254
43. C. Oslakovic, T. Cedervall, S. Linse, and B. Dahlbäck Polystyrene nanoparticles affecting blood coagulation Nanomedicine 2011 10.1016/j.nano.2011. 12.001
44. J. Laloy, S. Robert, C. Marbehant, F. Mullier, J. Mejia, J.P. Piret, S. Lucas, B. Chatelain, J.M. Dogne, O. Toussaint, B. Masereel, and S. Rolin Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials Nanotoxicology 6 2012 213 232
45. L. Fei, and S. Perrett Effect of nanoparticles on protein folding and fibrillogenesis Int. J. Mol. Sci. 10 2009 646 655
46. D. Brambilla, B. Le Droumaguet, J. Nicolas, S.H. Hashemi, L.-P. Wu, S.M. Moghimi, P. Couvreur, and K. Andrieux Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues Nanomedicine 7 2011 521 540
47. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-β protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84
48. S. Baglioni, F. Casamenti, M. Bucciantini, L.M. Luheshi, N. Taddei, F. Chiti, C.M. Dobson, and M. Stefani Prefibrillar amyloid aggregates could be generic toxins in higher organisms J. Neurosci. 26 2006 8160 8167
49. K. Ikeda, T. Okada, S.-i. Sawada, K. Akiyoshi, and K. Matsuzaki Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones FEBS Lett. 580 2006 6587 6595
50. C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, S. Lindman, A.M. Minogue, E. Thulin, D.M. Walsh, K.A. Dawson, and S. Linse Inhibition of amyloid β protein fibrillation by polymeric nanoparticles J. Am. Chem. Soc. 130 2008 15437 15443
51. S. Linse, C. Cabaleiro-Lago, W.-F. Xue, I. Lynch, S. Lindman, E. Thulin, S.E. Radford, and K.A. Dawson Nucleation of protein fibrillation by nanoparticles Proc. Natl. Acad. Sci. U.S.A. 104 2007 8691 8696
52. C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, K.A. Dawson, and S. Linse Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation ACS Chem. Neurosci. 1 2010 279 287
53. C. Oslakovic, M.J. Krisinger, A. Andersson, M. Jauhiainen, C. Ehnholm, and B. Dahlback Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins J. Biol. Chem. 284 2009 5896 5904
54. D.M. Walsh, E. Thulin, A.M. Minogue, N. Gustavsson, E. Pang, D.B. Teplow, and S. Linse A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide FEBS J. 276 2009 1266 1281
55. M.J. Krisinger, L.J. Guo, G.L. Salvagno, G.C. Guidi, G. Lippi, and B. Dahlback Mouse recombinant protein c variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma FEBS J. 276 2009 6586 6602
56. H. LeVine 3rd Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
57. H. Naiki, and F. Gejyo Kinetic analysis of amyloid fibril formation Methods Enzymol. 309 1999 305 318
58. H. Levine Thioflavin-T interaction with amyloid beta-sheet structures Amyloid 2 1995 1 6
59. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366
60. J.T. Jarrett, and P.T. Lansbury Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB Biochemistry 31 1992 12345 12352
61. M. Safi, J. Courtois, M. Seigneuret, H. Conjeaud, and J.F. Berret The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles Biomaterials 32 2011 9353 9363
62. S.H.D.P. Lacerda, J.J. Park, C. Meuse, D. Pristinski, M.L. Becker, A. Karim, and J.F. Douglas Interaction of gold nanoparticles with common human blood proteins ACS Nano 4 2009 365 379
63. H. Saito, P. Dhanasekaran, D. Nguyen, E. Deridder, P. Holvoet, S. Lund-Katz, and M.C. Phillips α-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids J. Biol. Chem. 279 2004 20974 20981
64. Y. Fang, O. Gursky, and D. Atkinson Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants Biochemistry 42 2003 13260 13268
65. M. Kono, Y. Okumura, M. Tanaka, D. Nguyen, P. Dhanasekaran, S. Lund-Katz, M.C. Phillips, and H. Saito Conformational flexibility of the N-terminal domain of apolipoprotein A-I bound to spherical lipid particles Biochemistry 47 2008 11340 11347
66. S. Lindman, I. Lynch, E. Thulin, H. Nilsson, K.A. Dawson, and S. Linse Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity Nano Lett. 7 2007 914 920